These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38006196)

  • 1. Cell Therapy Improves Quality-of-Life in Heart Failure: Outcomes From a Phase III Clinical Trial.
    Yamada S; Bartunek J; Povsic TJ; Cotter G; Davison BA; Edwards C; Behfar A; Metra M; Filippatos GS; Vanderheyden M; Wijns W; Terzic A
    Stem Cells Transl Med; 2024 Feb; 13(2):116-124. PubMed ID: 38006196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.
    Bartunek J; Terzic A; Davison BA; Filippatos GS; Radovanovic S; Beleslin B; Merkely B; Musialek P; Wojakowski W; Andreka P; Horvath IG; Katz A; Dolatabadi D; El Nakadi B; Arandjelovic A; Edes I; Seferovic PM; Obradovic S; Vanderheyden M; Jagic N; Petrov I; Atar S; Halabi M; Gelev VL; Shochat MK; Kasprzak JD; Sanz-Ruiz R; Heyndrickx GR; Nyolczas N; Legrand V; Guédès A; Heyse A; Moccetti T; Fernandez-Aviles F; Jimenez-Quevedo P; Bayes-Genis A; Hernandez-Garcia JM; Ribichini F; Gruchala M; Waldman SA; Teerlink JR; Gersh BJ; Povsic TJ; Henry TD; Metra M; Hajjar RJ; Tendera M; Behfar A; Alexandre B; Seron A; Stough WG; Sherman W; Cotter G; Wijns W;
    Eur Heart J; 2017 Mar; 38(9):648-660. PubMed ID: 28025189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of long-term effects of irbesartan on heart failure with preserved ejection fraction as measured by the minnesota living with heart failure questionnaire in the irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial.
    Rector TS; Carson PE; Anand IS; McMurray JJ; Zile MR; McKelvie RS; Komajda M; Kuskowski M; Massie BM;
    Circ Heart Fail; 2012 Mar; 5(2):217-25. PubMed ID: 22267751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life questionnaire predicts poor exercise capacity only in HFpEF and not in HFrEF.
    Ahmeti A; Henein MY; Ibrahimi P; Elezi S; Haliti E; Poniku A; Batalli A; Bajraktari G
    BMC Cardiovasc Disord; 2017 Oct; 17(1):268. PubMed ID: 29041912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Kansas City Cardiomyopathy Questionnaire and Minnesota Living With Heart Failure Questionnaire in Predicting Heart Failure Outcomes.
    Yee D; Novak E; Platts A; Nassif ME; LaRue SJ; Vader JM
    Am J Cardiol; 2019 Mar; 123(5):807-812. PubMed ID: 30587373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial.
    Chung ES; Miller L; Patel AN; Anderson RD; Mendelsohn FO; Traverse J; Silver KH; Shin J; Ewald G; Farr MJ; Anwaruddin S; Plat F; Fisher SJ; AuWerter AT; Pastore JM; Aras R; Penn MS
    Eur Heart J; 2015 Sep; 36(33):2228-38. PubMed ID: 26056125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial.
    Butler J; Filippatos G; Jamal Siddiqi T; Brueckmann M; Böhm M; Chopra VK; Pedro Ferreira J; Januzzi JL; Kaul S; Piña IL; Ponikowski P; Shah SJ; Senni M; Vedin O; Verma S; Peil B; Pocock SJ; Zannad F; Packer M; Anker SD
    Circulation; 2022 Jan; 145(3):184-193. PubMed ID: 34779658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fraction.
    Anker SD; Borggrefe M; Neuser H; Ohlow MA; Röger S; Goette A; Remppis BA; Kuck KH; Najarian KB; Gutterman DD; Rousso B; Burkhoff D; Hasenfuss G
    Eur J Heart Fail; 2019 Sep; 21(9):1103-1113. PubMed ID: 30652394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing Measures to Assess Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction.
    Napier R; McNulty SE; Eton DT; Redfield MM; AbouEzzeddine O; Dunlay SM
    JACC Heart Fail; 2018 Jul; 6(7):552-560. PubMed ID: 29885952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects and costs of home-based rehabilitation for heart failure with reduced ejection fraction: The REACH-HF multicentre randomized controlled trial.
    Dalal HM; Taylor RS; Jolly K; Davis RC; Doherty P; Miles J; van Lingen R; Warren FC; Green C; Wingham J; Greaves C; Sadler S; Hillsdon M; Abraham C; Britten N; Frost J; Singh S; Hayward C; Eyre V; Paul K; Lang CC; Smith K
    Eur J Prev Cardiol; 2019 Feb; 26(3):262-272. PubMed ID: 30304644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
    Zile MR; Lindenfeld J; Weaver FA; Zannad F; Galle E; Rogers T; Abraham WT
    J Am Coll Cardiol; 2020 Jul; 76(1):1-13. PubMed ID: 32616150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of drug and exercise intervention on functional capacity and quality of life in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials.
    Fukuta H; Goto T; Wakami K; Ohte N
    Eur J Prev Cardiol; 2016 Jan; 23(1):78-85. PubMed ID: 25520380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrillation in Patients With Preclinical and Overt Heart Failure With Preserved Ejection Fraction: The myPACE Randomized Clinical Trial.
    Infeld M; Wahlberg K; Cicero J; Plante TB; Meagher S; Novelli A; Habel N; Krishnan AM; Silverman DN; LeWinter MM; Lustgarten DL; Meyer M
    JAMA Cardiol; 2023 Mar; 8(3):213-221. PubMed ID: 36723919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Dyspnea Status During Hospitalization and Postdischarge Health-Related Quality of Life in Patients Hospitalized for Heart Failure: Findings From the EVEREST Trial.
    Ambrosy AP; Khan H; Udelson JE; Mentz RJ; Chioncel O; Greene SJ; Vaduganathan M; Subacuis HP; Konstam MA; Swedberg K; Zannad F; Maggioni AP; Gheorghiade M; Butler J
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27140204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life and chronic heart failure therapy guided by natriuretic peptides: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study.
    Bhardwaj A; Rehman SU; Mohammed AA; Gaggin HK; Barajas L; Barajas J; Moore SA; Sullivan D; Januzzi JL
    Am Heart J; 2012 Nov; 164(5):793-799.e1. PubMed ID: 23137512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does home oxygen therapy (HOT) in addition to standard care reduce disease severity and improve symptoms in people with chronic heart failure? A randomised trial of home oxygen therapy for patients with chronic heart failure.
    Clark AL; Johnson M; Fairhurst C; Torgerson D; Cockayne S; Rodgers S; Griffin S; Allgar V; Jones L; Nabb S; Harvey I; Squire I; Murphy J; Greenstone M
    Health Technol Assess; 2015 Sep; 19(75):1-120. PubMed ID: 26393373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life in patients with heart failure and improved ejection fraction: one-year changes and prognosis.
    Zamora E; González B; Lupón J; Borrellas A; Domingo M; Santiago-Vacas E; Cediel G; Codina P; Rivas C; Pulido A; Crespo E; Velayos P; Diaz V; Bayes-Genis A
    ESC Heart Fail; 2022 Dec; 9(6):3804-3813. PubMed ID: 35916351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life and outcomes in heart failure patients with ejection fractions in different ranges.
    Chen X; Xin Y; Hu W; Zhao Y; Zhang Z; Zhou Y
    PLoS One; 2019; 14(6):e0218983. PubMed ID: 31247042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive servo-ventilation for sleep-disordered breathing in patients with heart failure with reduced ejection fraction (ADVENT-HF): a multicentre, multinational, parallel-group, open-label, phase 3 randomised controlled trial.
    Bradley TD; Logan AG; Lorenzi Filho G; Kimoff RJ; Durán Cantolla J; Arzt M; Redolfi S; Parati G; Kasai T; Dunlap ME; Delgado D; Yatsu S; Bertolami A; Pedrosa R; Tomlinson G; Marin Trigo JM; Tantucci C; Floras JS;
    Lancet Respir Med; 2024 Feb; 12(2):153-166. PubMed ID: 38142697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Study of Heart Failure with Left Ventricular Ejection Fraction Regimen Treated with Entresto.
    Feng M; He B; Wang B; Chen X; Chu H
    Contrast Media Mol Imaging; 2022; 2022():4164089. PubMed ID: 36034207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.